Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.
Swerdlow SH.
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):90-9. doi: 10.1182/asheducation-2014.1.90. Epub 2014 Nov 18.
Double-hit B-cell lymphomas.
Aukema SM, Siebert R, Schuuring E, van Imhoff GW, Kluin-Nelemans HC, Boerma EJ, Kluin PM.
Blood. 2011 Feb 24;117(8):2319-31. doi: 10.1182/blood-2010-09-297879. Epub 2010 Nov 30.
The gray zone between Burkitt's lymphoma and diffuse large B-cell lymphoma from a genetics perspective.
Salaverria I, Siebert R.
J Clin Oncol. 2011 May 10;29(14):1835-43. doi: 10.1200/JCO.2010.32.8385. Epub 2011 Apr 11.
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.
Maruyama D, Watanabe T, Maeshima AM, Nomoto J, Taniguchi H, Azuma T, Mori M, Munakata W, Kim SW, Kobayashi Y, Matsuno Y, Tobinai K.
Int J Hematol. 2010 Dec;92(5):732-43. doi: 10.1007/s12185-010-0728-0. Epub 2010 Dec 1.
[B-cell lymphoma, unclassifiable, intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma].
Baryakh EA, Misyurina AE, Kovrigina AM, Misyurin VA, Kravchenko SK.
Ter Arkh. 2015;87(4):91-97. doi: 10.17116/terarkh201587491-97.
Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public Hospital.
Sissolak G, Seftel M, Uldrick TS, Esterhuizen TM, Mohamed N, Kotze D.
J Glob Oncol. 2016 Aug 31;3(3):218-226. doi: 10.1200/JGO.2015.002378. eCollection 2017 Jun.
Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Lin P, Dickason TJ, Fayad LE, Lennon PA, Hu P, Garcia M, Routbort MJ, Miranda R, Wang X, Qiao W, Medeiros LJ.
Cancer. 2012 Mar 15;118(6):1566-73. doi: 10.1002/cncr.26433. Epub 2011 Aug 31.
Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
Wang W, Hu S, Lu X, Young KH, Medeiros LJ.
Am J Surg Pathol. 2015 Aug;39(8):1132-9. doi: 10.1097/PAS.0000000000000434.
Diagnosis of Burkitt Lymphoma and Related High-Grade B-Cell Neoplasms.
Sohani AR, Hasserjian RP.
Surg Pathol Clin. 2010 Dec;3(4):1035-59. doi: 10.1016/j.path.2010.09.010. Epub 2010 Nov 27.
MYC/BCL2 double-hit high-grade B-cell lymphoma.
Li S, Lin P, Young KH, Kanagal-Shamanna R, Yin CC, Medeiros LJ.
Adv Anat Pathol. 2013 Sep;20(5):315-26. doi: 10.1097/PAP.0b013e3182a289f2.
